Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism

Authors:
  • HRHans Rommelspacher
    Hans Rommelspacher
  • SKSilke Kuhn
    Silke Kuhn
  • PDPeter Dufeu
    Peter Dufeu
  • GOGabriele Otto
    Gabriele Otto
  • MDMichael Dettling
    Michael Dettling
  • MVMario Giraldo Velasquez
    Mario Giraldo Velasquez
  • JPJorg Pelz
    Jorg Pelz
  • KGKlaus Jurgen Graf
    Klaus Jurgen Graf
  • HHHelmut Harms
    Helmut Harms
  • TSThomas Sander
    Thomas Sander

Abstract
The present study was performed to test the hypotheses that allelic variants at the human dopamine D2 receptor gene locus (DRD2) confer susceptibility to alcoholism or are associated with clinical subtypes of alcoholism. We investigated anA^G substitution polymorphism in the 3'-untranslated region of exon 8 (E8) of DRD2 with allele frequencies of/G=0.295 - 0.329. No significant association of the DRD2 genotype or allele frequencies with alcoholism was found in an association study including 283 alcoholics and 146 non-alcoholic controls. However, the frequent homozygous E8 A/A genotype with fAA=0.47 - 0.48 was associated with increased anxiety and depression scores in alcoholics during the follow up after clinical detoxification treatment. In addition, E8 A/A was associated with increased suicide attempts and showed a tendency towards more severe withdrawal symptoms, early relapse and reduced responsiveness to the dopaminergic agonist apomorphine. Regression analysis revealed the DRD2 E8 genotype as the only significant factor determining withdrawal severity in female alcoholics. The findings suggest an influence of the DRD2 genotype on the neuropharmacological effects of chronic alcohol exposure and the clinical course of alcoholism.